According to the latest report published by Credence Research, Inc. “Apheresis Equipment industry (Products: Devices & Disposable Kits; Technology: Centrifugation & Membrane Filtration; Procedure: Plasmapheresis, LDL-apheresis, Plateletpheresis, Leukapheresis, Photophereis, Erythrocytapheresis & Others; Application: Renal, Neurology, hematology & Others): Growth, Future Prospects and Competitive Analysis, 2016-2023,” the apheresis equipment industry was valued at USD 1,739.8 Bn in 2015, and is expected to reach USD 3,002.2 Bn by 2023, expanding at a CAGR of 6.9% from 2016 to 2023.
Browse the full report Apheresis Equipment: industry Growth, Future Prospects and Competitive Analysis, 2016-2023 report at http://www.credenceresearch.com/report/apheresis-equipment-market
Escalating incidence of hematological disorders has resulted in rise in demand for platelets and plasma products, thus driving the apheresis equipment industry worldwide. This industry growth of apheresis equipment is also supported by rapid technological developments and product innovations. Favorable reimbursements and growing demand for photopheresis will allow stability to the global apheresis equipment industry.
Between apheresis devices and disposable kits, the later segment takes the larger industry share on the grounds of cheap costs and frequent purchase. Additionally, the apheresis devices segment will witness high growth during the forecast period. This progress is attributed to the demand for automated equipment and rapid development of healthcare infrastructure and rising healthcare expenditure in the emerging economies. Among the applications, neurology is the largest segment. Therapeutic apheresis is widely used in treating neurological conditions such as autoimmune diseases and multiple sclerosis.
Based on procedure types, plasmapheresis accounts for the largest share due to growing incidence of hematological conditions, cardiovascular diseases that require plasma transfusion and increasing demand for plasma products. In addition, photopheresis segment is anticipated to witness the fastest industry growth during the forecast period on the ground of its established efficiency in treating CTCL. Between centrifugation and membrane filtration, membrane filtration has been the most preferred technology for performing apheresis.
This global apheresis equipment is highly competitive and is governed by technological development. Regional dominance of a few players is a chief feature of this industry. Moreover, the disposable kits segment is more scattered in nature and is characterized by presence of several local players. Some of the most significant players in the global apheresis equipment industry include Haemonetics Corporation, Terumo BCT, Inc., HemaCare Corporation, Asahi Kasei Kuraray Medical Co., Ltd., Fenwal, Inc., B Braun Melsungen AG, Medica SpA, Feresenius Kabi, Cerus Corporation, Kawasumi Laboratories Inc., Kaneka Corporation, Nikkiso Co., Ltd., Therakos, Inc. and others.
Intraoperative Imaging industry By Imaging Type (Intraoperative Computed Tomography (CT), Intraoperative Magnetic Resonance Imaging (MRI), Intraoperative Ultrasound) – Growth, Share, Opportunities & Competitive Analysis, 2015 -2022
Healthcare Analytical Testing: industry Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2020
Request Free Sample: http://www.credenceresearch.com/sample-request/58047
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States